Billion Dollar Code: how start-ups can win the Quids Game
Parminder Lally’s article shows start-ups how to avoid the mistakes made by the start-up in Netflix’s The Billion Dollar Code.
Read more
Patenting computer simulations: the fusion sector
The UK Atomic Energy Authority (UKAEA) and the Science and Technologies Facilities Council (STFC) recently started a new collaboration
Read more
Oatly loses battle of the oat drinks
The recent case concerning oat-based drinks OATLY and PURE OATY highlights the difficulties in enforcing rights in a descriptive trade mark against third parties.
Read more
The Greenshoots Podcast by Appleyard Lees – episode 18 – filing multidisciplinary patents
In this episode, patent attorneys and Appleyard Lees partners Barbara Fleck, Julia Gwilt and Howard Read, discuss the difficulties of obtaining a patent involving both biotech and software, and the importance of a multidisciplinary team of patent attorneys.
Read more
Intellectual property for start-ups in a post-COVID world: part three – managing commercial IP
This series of articles explores the effect of COVID-19-related disruption on start-ups’ management and monetisation of intellectual property (IP), giving practical guidance to start-ups to improve and preserve their position
Read more
A brief guide to patenting diagnostic inventions in Europe
Inventions can be broadly split into products (i.e. physical entities) and methods (i.e. activities). This brief guide aims to clarify exactly which diagnostic products and methods can and cannot currently be patented in Europe.
Read more
The University of Cambridge fight over Cambridge Blue
In a recent decision, the UK Intellectual Property Office found in favour of Cambridge University and upheld an opposition against a trade mark application for CAMBRIDGE BLUE.
Read more
Exhaustion regime post-Brexit – A new UK consultation
The Brexit transition period came to an end on 31 December 2020 and as of 1 January 2021 the UK was no longer bound by EU legal framework. Before the UK left the EU, the UK was party to the EU’s regional exhaustion of IP rights regime.
Read more
Is it worth patenting your AI tools for drug discovery?
Often, when the AI identifies a drug, and experiments confirm it is useful for the intended purpose, the drug can be patented. But what about the AI itself – can the AI be protected by patents, and should you try to?
Read more The Greenshoots Podcast by Appleyard Lees – episode 16 – the entrepreneurial journey of Mags Walker, founder of the fabl and Toolally.
Serial entrepreneur Mags Walker joins Appleyard Lees partner and solicitor Chris Hoole to talk about her journey from 'Big Four' accountant to owner of two successful start-up businesses.
Read more
Someone’s copying my invention! What should I do?
What do you do if, before you have obtained a granted patent, a third party starts selling a product that looks like your invention? Is there anything you can do to stop the third party? Does your patent application provide you with any rights before the patent is granted? Parminder Lally and Simon Ambroz answer these questions.
Read more
